TEAD4 Identified as a Potential Biomarker for Gastric Cancer Via Genes Associated with Liquid-Liquid Phase Separation | Synapse
March 3, 2026
TEAD4 Identified as a Potential Biomarker for Gastric Cancer Via Genes Associated with Liquid-Liquid Phase Separation
Key Points
The study aims to explore TEAD4's role in gastric cancer (GC) and its potential as a biomarker.
Identified genes associated with liquid-liquid phase separation
Analyzed TEAD4's contribution to gastric cancer progression
Examined implications for diagnosis and prognosis
TEAD4 is linked to gastric cancer progression
Suggests potential for use in diagnosis and prognosis
Indicates involvement in immune infiltration
Abstract
TEAD4 contributes to GC progression and may serve as a biomarker for diagnosis, prognosis, and immune infiltration, providing insights for potential therapeutic strategies.